{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:39:16Z","timestamp":1784770756585,"version":"3.55.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bacteria can cause life-threatening infections, such as pneumonia, meningitis, or sepsis. Antibiotic therapy is a mainstay of treatment, although antimicrobial resistance has drastically increased over the years. Unfortunately, safe and effective vaccines against most pathogens have not yet been approved, and thus developing alternative treatments is important. We analyzed the efficiency of factor H (FH)6-7\/Fc, a novel antibacterial immunotherapeutic protein against the Gram-positive bacterium Streptococcus pyogenes. This protein is composed of two domains of complement inhibitor human FH (FH complement control protein modules 6 and 7) that bind to S. pyogenes, linked to the Fc region of IgG (FH6-7\/Fc). FH6-7\/Fc has previously been shown to enhance complement-dependent killing of, and facilitate bacterial clearance in, animal models of the Gram-negative pathogens Haemophilus influenzae and Neisseria meningitidis. We hypothesized that activation of complement by FH6-7\/Fc on the surface of Gram-positive bacteria such as S. pyogenes will enable professional phagocytes to eliminate the pathogen. We found that FH6-7\/Fc alleviated S. pyogenes\u2013induced sepsis in a transgenic mouse model expressing human FH (S. pyogenes binds FH in a human-specific manner). Furthermore, FH6-7\/Fc, which binds to protein H and selected M proteins, displaced FH from the bacterial surface, enhanced alternative pathway activation, and reduced bacterial blood burden by opsonophagocytosis in a C3-dependent manner in an ex vivo human whole-blood model. In conclusion, FH-Fc chimeric proteins could serve as adjunctive treatments against multidrug-resistant bacterial infections.<\/jats:p>","DOI":"10.4049\/jimmunol.1700426","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T13:15:11Z","timestamp":1509369311000},"page":"3828-3839","source":"Crossref","is-referenced-by-count":27,"title":["Factor H\u2013IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen <i>Streptococcus pyogenes<\/i>"],"prefix":"10.1093","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-1734","authenticated-orcid":false,"given":"Anna M","family":"Blom","sequence":"first","affiliation":[{"name":"Department of Translational Medicine, Medical Protein Chemistry, Lund University, Sk\u00e5ne County Council , Malm\u00f6 20502,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-0769","authenticated-orcid":false,"given":"Michal","family":"Magda","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Medical Protein Chemistry, Lund University, Sk\u00e5ne County Council , Malm\u00f6 20502,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kohl","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Medical Protein Chemistry, Lund University, Sk\u00e5ne County Council , Malm\u00f6 20502,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutamas","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical School , Worcester, MA 01605"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-5776","authenticated-orcid":false,"given":"John D","family":"Lambris","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania , Philadelphia, PA 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ram","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical School , Worcester, MA 01605"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-9070","authenticated-orcid":false,"given":"David","family":"Ermert","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Medical Protein Chemistry, Lund University, Sk\u00e5ne County Council , Malm\u00f6 20502,","place":["Sweden"]},{"name":"Division of Infectious Diseases and Immunology, University of Massachusetts Medical School , Worcester, MA 01605"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"2025030614542560100_r1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections of skin and soft tissues","volume":"334","author":"Bisno","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"2025030614542560100_r2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1126\/science.8209244","article-title":"Flesh-eating bacteria: not new, but still worrisome","volume":"264","author":"Nowak","year":"1994","journal-title":"Science"},{"key":"2025030614542560100_r3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"2025030614542560100_r4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1073\/pnas.85.5.1657","article-title":"Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H","volume":"85","author":"Horstmann","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030614542560100_r5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.1994.tb01003.x","article-title":"Protein H\u2014a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin","volume":"12","author":"Frick","year":"1994","journal-title":"Mol. Microbiol."},{"key":"2025030614542560100_r6","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/j.1460-2075.1995.tb07156.x","article-title":"Protein H\u2014a bacterial surface protein with affinity for both immunoglobulin and fibronectin type III domains","volume":"14","author":"Frick","year":"1995","journal-title":"EMBO J."},{"key":"2025030614542560100_r7","doi-asserted-by":"crossref","first-page":"32172","DOI":"10.1074\/jbc.M113.502955","article-title":"Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells","volume":"288","author":"Ermert","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2025030614542560100_r8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.154.1.375","article-title":"Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system","volume":"154","author":"Thern","year":"1995","journal-title":"J. Immunol."},{"key":"2025030614542560100_r9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2958.2005.04527.x","article-title":"Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway","volume":"56","author":"Carlsson","year":"2005","journal-title":"Mol. Microbiol."},{"key":"2025030614542560100_r10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000353754","article-title":"Plasmin(ogen) acquisition by group A Streptococcus protects against C3b-mediated neutrophil killing","volume":"6","author":"Ly","year":"2014","journal-title":"J. Innate Immun."},{"key":"2025030614542560100_r11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20030543","article-title":"Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein","volume":"198","author":"Carlsson","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025030614542560100_r12","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.4049\/jimmunol.157.7.3021","article-title":"A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP","volume":"157","author":"Johnsson","year":"1996","journal-title":"J. Immunol."},{"key":"2025030614542560100_r13","doi-asserted-by":"crossref","first-page":"e1005043","DOI":"10.1371\/journal.ppat.1005043","article-title":"Virulence of group A streptococci is enhanced by human complement inhibitors","volume":"11","author":"Ermert","year":"2015","journal-title":"PLoS Pathog."},{"key":"2025030614542560100_r14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2025030614542560100_r15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I\u2014molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"2025030614542560100_r16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"key":"2025030614542560100_r17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/mr.47.1.46-83.1983","article-title":"Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria","volume":"47","author":"Taylor","year":"1983","journal-title":"Microbiol. Rev."},{"key":"2025030614542560100_r18","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/1873-3468.12284","article-title":"Self-nonself discrimination by the complement system","volume":"590","author":"Meri","year":"2016","journal-title":"FEBS Lett."},{"key":"2025030614542560100_r19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.molimm.2003.12.002","article-title":"Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?","volume":"40","author":"Blom","year":"2004","journal-title":"Mol. Immunol."},{"key":"2025030614542560100_r20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.imlet.2015.11.014","article-title":"C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend","volume":"169","author":"Ermert","year":"2016","journal-title":"Immunol. Lett."},{"key":"2025030614542560100_r21","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00018-016-2418-4","article-title":"Complement factor H in host defense and immune evasion","volume":"74","author":"Parente","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"2025030614542560100_r22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol. Rev."},{"key":"2025030614542560100_r23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3389\/fmicb.2016.02004","article-title":"Hijacking complement regulatory proteins for bacterial immune evasion","volume":"7","author":"Hovingh","year":"2016","journal-title":"Front. Microbiol."},{"key":"2025030614542560100_r24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2005.06.016","article-title":"Complement escape of human pathogenic bacteria by acquisition of complement regulators","volume":"43","author":"Kraiczy","year":"2006","journal-title":"Mol. Immunol."},{"key":"2025030614542560100_r25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/iai.65.2.484-487.1997","article-title":"Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptococcus pyogenes M protein","volume":"65","author":"Sharma","year":"1997","journal-title":"Infect. Immun."},{"key":"2025030614542560100_r26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.imbio.2016.05.016","article-title":"Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: lessons from the pathogenic Neisseriae","volume":"221","author":"Ram","year":"2016","journal-title":"Immunobiology"},{"key":"2025030614542560100_r27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj2240389","article-title":"Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H","volume":"224","author":"Alsenz","year":"1984","journal-title":"Biochem. J."},{"key":"2025030614542560100_r28","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"key":"2025030614542560100_r29","article-title":"Antibiotic resistance threats in the United States","volume-title":"CDC Reports. Department of Health and Human Services.","author":"U.S. Department of Health and Human Services Centers for Disease Control and Prevention"},{"key":"2025030614542560100_r30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","article-title":"Update on the antibiotic resistance crisis","volume":"18","author":"Rossolini","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"2025030614542560100_r31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"2025030614542560100_r32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.molimm.2010.05.007","article-title":"Complement control protein factor H: the good, the bad, and the inadequate","volume":"47","author":"Ferreira","year":"2010","journal-title":"Mol. Immunol."},{"key":"2025030614542560100_r33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fcimb.2016.00040","article-title":"Defining the binding region in factor H to develop a therapeutic factor H-Fc fusion protein against non-typeable Haemophilus influenzae","volume":"6","author":"Wong","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2025030614542560100_r34","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1128\/CVI.00444-14","article-title":"Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic","volume":"21","author":"Shaughnessy","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"2025030614542560100_r35","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.1500292","article-title":"A novel factor H-Fc chimeric immunotherapeutic molecule against Neisseria gonorrhoeae","volume":"196","author":"Shaughnessy","year":"2016","journal-title":"J. Immunol."},{"key":"2025030614542560100_r36","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1046\/j.1365-2958.2000.01942.x","article-title":"Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein","volume":"36","author":"Collin","year":"2000","journal-title":"Mol. Microbiol."},{"key":"2025030614542560100_r37","doi-asserted-by":"crossref","first-page":"20774","DOI":"10.1074\/jbc.272.33.20774","article-title":"Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets","volume":"272","author":"Berge","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2025030614542560100_r38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0882-4010(96)80003-9","article-title":"Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga","volume":"19","author":"Kihlberg","year":"1995","journal-title":"Microb. Pathog."},{"key":"2025030614542560100_r39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1042\/bj3000877","article-title":"M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes","volume":"300","author":"Akesson","year":"1994","journal-title":"Biochem. J."},{"key":"2025030614542560100_r40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/BF01120205","article-title":"Monoclonal antibodies against the complement control protein factor H (\u03b21 H)","volume":"3","author":"Sim","year":"1983","journal-title":"Biosci. Rep."},{"key":"2025030614542560100_r41","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-08-0201","article-title":"Optimization of antibody binding to Fc\u03b3RIIa enhances macrophage phagocytosis of tumor cells","volume":"7","author":"Richards","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"2025030614542560100_r42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.imbio.2012.06.003","article-title":"New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties","volume":"218","author":"Qu","year":"2013","journal-title":"Immunobiology"},{"key":"2025030614542560100_r43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC\/ISTH","volume":"11","author":"Cattaneo","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"2025030614542560100_r44","doi-asserted-by":"crossref","first-page":"38473","DOI":"10.1074\/jbc.M110.143727","article-title":"Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels","volume":"285","author":"Reuter","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025030614542560100_r45","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/IAI.66.4.1427-1431.1998","article-title":"M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H","volume":"66","author":"Blackmore","year":"1998","journal-title":"Infect. Immun."},{"key":"2025030614542560100_r46","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira","year":"2009","journal-title":"J. Immunol."},{"key":"2025030614542560100_r47","doi-asserted-by":"crossref","first-page":"S537","DOI":"10.1093\/clinids\/9.Supplement_5.S537","article-title":"The function of antibody and complement in the lysis of bacteria","volume":"9","author":"Frank","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"2025030614542560100_r48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.iy.02.040184.002333","article-title":"Complement and bacteria: chemistry and biology in host defense","volume":"2","author":"Joiner","year":"1984","journal-title":"Annu. Rev. Immunol."},{"key":"2025030614542560100_r49","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1073\/pnas.73.9.3268","article-title":"Control of the amplification convertase of complement by the plasma protein beta1H","volume":"73","author":"Weiler","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030614542560100_r50","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.948757","article-title":"Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator","volume":"193","author":"Whaley","year":"1976","journal-title":"Science"},{"key":"2025030614542560100_r51","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1084\/jem.148.4.1044","article-title":"Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator","volume":"148","author":"Fujita","year":"1978","journal-title":"J. Exp. Med."},{"key":"2025030614542560100_r52","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1073\/pnas.76.12.6596","article-title":"Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator","volume":"76","author":"Gigli","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030614542560100_r53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4049\/jimmunol.1102545","article-title":"Acquisition of complement factor H is important for pathogenesis of Streptococcus pyogenes infections: evidence from bacterial in vitro survival and human genetic association","volume":"188","author":"Haapasalo","year":"2012","journal-title":"J. Immunol."},{"key":"2025030614542560100_r54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2958.2008.06347.x","article-title":"Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes","volume":"70","author":"Haapasalo","year":"2008","journal-title":"Mol. Microbiol."},{"key":"2025030614542560100_r55","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/IAI.67.4.1708-1714.1999","article-title":"Protein H, an antiphagocytic surface protein in Streptococcus pyogenes","volume":"67","author":"Kihlberg","year":"1999","journal-title":"Infect. Immun."},{"key":"2025030614542560100_r56","doi-asserted-by":"crossref","first-page":"e1003323","DOI":"10.1371\/journal.ppat.1003323","article-title":"Factor H binds to the hypervariable region of many Streptococcus pyogenes M proteins but does not promote phagocytosis resistance or acute virulence","volume":"9","author":"Gustafsson","year":"2013","journal-title":"PLoS Pathog."},{"key":"2025030614542560100_r57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0161-5890(90)90071-7","article-title":"Protein H\u2014a novel IgG binding bacterial protein","volume":"27","author":"Akesson","year":"1990","journal-title":"Mol. Immunol."},{"key":"2025030614542560100_r58","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/cmi.12170","article-title":"Distinct localization of the complement C5b-9 complex on Gram-positive bacteria","volume":"15","author":"Berends","year":"2013","journal-title":"Cell. Microbiol."},{"key":"2025030614542560100_r59","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1242\/jcs.179291","article-title":"Complement-mediated \u201cbystander\u201d damage initiates host NLRP3 inflammasome activation","volume":"129","author":"Suresh","year":"2016","journal-title":"J. Cell Sci."},{"key":"2025030614542560100_r60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J. Exp. Med."},{"key":"2025030614542560100_r61","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"2025030614542560100_r62","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/eji.200424850","article-title":"Critical role for complement receptor 3 (CD11b\/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum","volume":"35","author":"Nilsson","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"2025030614542560100_r63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2015.11.002","article-title":"Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40","volume":"162","author":"Wang","year":"2016","journal-title":"Clin. Immunol."},{"key":"2025030614542560100_r64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2001.1800110.x","article-title":"Structure-function relationships of complement receptor type 1","volume":"180","author":"Krych-Goldberg","year":"2001","journal-title":"Immunol. Rev."},{"key":"2025030614542560100_r65","author":"World Health Organization","year":"2017"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/199\/11\/3828\/61592693\/ji1700426.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/199\/11\/3828\/61592693\/ji1700426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:56:31Z","timestamp":1741280191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/199\/11\/3828\/7977083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1700426","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,12,1]]}}}